It is a great pleasure to introduce this special issue of Immunologic Research on the 9th International Congress on Autoimmunity held in Nice, France, on March 26-30, 2014. This special edition highlights a broad spectrum of emerging issues in the field of autoimmune diseases, both through original studies, reviews and case reports.
Nice area and most particularly Grasse (France) might be the sweetest smelling city in Europe, widely known as the perfume capital in the world. While a superior olfactory sense, like that of Jean Baptiste Grenouille, the antihero of Patrick Süskind's novel Perfume, may lead to addiction and psychiatric diseases, some olfactory function has been found to be impaired in patients affected by variety of autoimmune diseases. Recently, several studies have reported olfactory disorders in various immune-mediated diseases [1] including systemic lupus erythematosus (SLE) [2] . In this issue, two articles evaluate for the first time olfactory function in patients with idiopathic inflammatory myopathies (IIM) [3] , fibromyalgia (FM) and systemic sclerosis (SSc) [4] . Thus, Iaccarino et al. [3] performed a case-control study in 60 patients with IIM using the Sniffin' Sticks test, based on threshold, discrimination and identification (TDI) of odors. TDI score was found to be significantly lower in IIM patients when compared to ageand sex-matched healthy control individuals. Similarly, Amital et al. [4] investigated olfactory function in 24 patients with FM compared to 20 SSc and age-matched healthy controls. They demonstrated that TDI score was significantly decreased in FM and SSc compared with controls, the sense of smell being more deeply altered in patients with FM. The mechanisms of smell system damage in patients with autoimmune diseases are still elusive and are though to result from a complex interplay between genetic, environmental and hormonal factors [1] . In both articles, the role of depression as a potential confounding factor is still unclear. Unfortunately, none of these studies explored potential pathophysiological processes. Whether olfactory function may parallel disease activity or outcome should also be explored.
Many women report a heightened sense of smell during pregnancy. Accounts of these anecdotes have existed for over 100 years, but scientific evidence has been sparse and inconclusive. A recent review [5] examined the literature on olfactory perception during pregnancy, showing no support for a general decrease in olfactory thresholds. This special issue examined more conventional aspects of pregnancy in the context of autoimmunity. Two authors have questioned predictive factors of SLE flares as well as of obstetric and fetal complications during pregnancy [6, 7] . Despite considerable progress in the identification of pre-conception, per pregnancy and puerperium risk factors for lupus flare, summarized by Jara et al. [7] , it appears that predictive factors in pregnancy have not been systematically and fully elucidated. However, by prospectively following 132 pregnancies in 96 SLE patients, Borella et al. [6] reported that the number of flares before conception best predicted the risk of lupus flares during pregnancy. Moreover, manifestations during flares were even best predicted by the same features occurred before conception, illustrating Thucydides' quote ''History eternally repeats itself.'' In the search for new markers of activity, serum soluble CD163 (sCD163), a marker of activity of monocytes and macrophages identified there a decade [8] , emerged recently as a new marker of activity in both metabolic [8] , hepatic [9] , infectious [10] or autoimmune diseases, including rheumatoid arthritis and scleroderma [11, 12] . Colafranscesco et al. [13] report the first study regarding the evaluation of sCD163 in patients with adult onset Still's disease (AOSD). They demonstrated that sCD163 was positively correlated with ferritin only in AOSD patients, sustaining the hypothesis that in this condition, hyperferritinemia is related to macrophage activation. Furthermore, while sCD163 was diffusely expressed into the AOSD lymph node, for the first time, they demonstrated that ferritin is expressed only in the B cell area, suggesting a role for this molecule as antigen in course of AOSD.
Recent decades have also been marked by major questions regarding the involvement of vaccines in the occurrence of autoimmune phenomena. Specifically, the hepatitis B vaccine has long been suspected to promote autoimmunity especially demyelinating diseases of the central nervous system. This is still a controversial topic since the scientific evidence establishing a clear causal link between vaccines and the onset of autoimmune diseases is missing. On these grounds, Le Houézec [14] compared in this issue temporal hepatitis B vaccine dose distribution and multiple sclerosis (MS) occurrence in the French population, using the official data collected by the French pharmacovigilance system (ANSM) and the national health insurance (CNAM). According to the author, their data confirm, at the global population level, a significant correlation between the number of immunizations and both the number of MS cases declared to the pharmacovigilance system one to two years later and an overall increase of identified MS cases in the country. These data revive the debate in the never ending French saga [15] although it should be read critically in regard to the methodology. Also in the spotlight, the emerging role of Human Papilloma Virus HPV-16/18 AS04-adjuvanted vaccine in the occurrence of subsequent autoimmune diseases [16] is addressed in this special issue. Poddighe et al. [17] report one case of pseudo-neurological symptoms following HPV vaccine and discuss these symptoms as a part of the emergent feature of autoimmune/inflammatory syndrome induced by adjuvants (ASIA) [18] . Very recently, yet another study examined whether vaccines may increase the risk of multiple sclerosis or other central nervous system demyelinating syndromes (CNS ADS) [19] . A rigorous nested casecontrol study was conducted using data obtained from the complete electronic health records of Kaiser Permanente Southern California members. Five controls per case were matched on age, sex and zip code. Vaccination of any type, particularly hepatitis B and human papillomavirus, was identified through the electronic vaccination records system. The authors found no longer-term association of vaccines with MS or any other CNS ADS, which argues against a causal association.
This special issue on the Frontiers of Immunology also provides new fields of investigation in basic research. Indeed, research into the understanding of the different protagonists involved in the pathogenesis of autoimmune diseases is moving forward at a rapid pace. Functional or quantitative defect in T regulatory population is a key abnormality observed in many autoimmune diseases. In recent years [20] , antigen-specific cellular immune responses toward several normal self-proteins expressed in regulatory immune T cells have been reported, especially in patients with cancer. Thus, a specific population of cytotoxic T cells can eliminate regulatory T cells. Interestingly, these self-reactive T cells might be important in the fine-tuning of the immune system. Herein, Andersen [21] reviews the roles of these self-reactive T cells in autoimmunity, suggesting a novel therapeutic target.
In addition, environmental factors including virus are also widely recognized as playing an important role in the occurrence of autoimmune phenomena [22] . In this issue, Temajo and Howard [23] specify how virus and virusinduced Heat Shock Protein (HSP) manipulate antigen presenting cells (APCs), thereby promoting the development of autoimmunity.
This issue proposes a comprehensive review of the literature by Lazurova et al. [24] , on the prevalence of autoimmune thyroid disease (AITD) and antithyroid autoantibodies in rheumatoid arthritis (RA) patients and rheumatic manifestations in association with thyroid autoimmunity. They review the role of genetics in the association of both AITD and RA.
Finally, so dear to the internists' heart, a rare case is addressed in this issue. Gueta et al. [25] report the fourth literature case of cryptogenic organizing pneumonia with a hypogammaglobulinemia state. This constitutes the first reported case of a selective immune deficiency state treated successfully with intravenous immune globulins.
The articles in this issue illustrate just a portion of the breadth of immunology research, spanning basic to translational and clinical immunology research. This is the exact reflection of what the International Congress on Autoimmunity proposes to participants.
